Questionnaire for Ovarian Cancer Patients Regarding Acceptance and Willingness to Undergo Genetic Testing

Ovarian Cancer Patient Questionnaire on Genetic Testing

Sponsors

Lead sponsor: M.D. Anderson Cancer Center

Source M.D. Anderson Cancer Center
Brief Summary

The objective of this study is to evaluate the willingness of patients with ovarian cancer to undergo genetic testing, given the cost, their understanding and acceptance of genetic testing and the possibility of targeted therapy.

Detailed Description

All eligible patients being seen in the Gynecology Center at the M.D. Anderson Cancer Center and at Gynecologic Oncology of Houston for follow-up or a new diagnosis of ovarian cancer will be asked to participate in this study by completing a questionnaire.

This study will end when 400 completed questionnaires have been collected. We estimate that 40-60 ovarian cancer patients are seen in the Gynecology Center at the M.D. Anderson Cancer Center each week and that 20- 40 ovarian cancer patients are seen at Gynecologic Oncology of Houston each week. The completion of 400 questionnaires will provide adequate data to address our question in an expeditious time frame. The initial phase of this study is exploratory and does not involve a comparison group.

Overall Status Completed
Start Date June 2007
Completion Date October 2008
Primary Completion Date October 2008
Study Type Observational
Primary Outcome
Measure Time Frame
Participants' Response to Survey Questions (Yes/No) 15-20 minutes to complete survey
Enrollment 237
Condition
Intervention

Intervention type: Behavioral

Intervention name: Questionnaire

Description: A questionnaire will be completed.

Arm group label: Patients with ovarian cancer

Other name: Survey

Eligibility

Sampling method: Non-Probability Sample

Criteria:

Inclusion Criteria:

- Patients must have the diagnosis of ovarian cancer.

- Patients must be at least 18 years of age at the time of enrollment.

- Patients must be able to read and write in the English language.

Exclusion Criteria:

- Patients that are unable to speak or write in the English language. Currently, the investigators' resources in genetic counseling are limited. In the future, they plan to expand the questionnaire and study to include additional languages.

- Patients having previously undergone BRCA genetic testing.

Gender: Female

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: No

Overall Official
Last Name Role Affiliation
Karen H. Lu, MD Principal Investigator M.D. Anderson Cancer Center
Location
facility
U.T.M.D. Anderson Cancer Center
Location Countries

United States

Verification Date

July 2012

Responsible Party

Responsible party type: Sponsor

Keywords
Has Expanded Access No
Condition Browse
Arm Group

Arm group label: Patients with ovarian cancer

Study Design Info

Observational model: Case-Only

Time perspective: Prospective

Source: ClinicalTrials.gov